Younger women with breast cancer were more likely than older women to undergo immediate breast reconstruction (IBR), according to a study involving >320,000 individuals. Additionally, tumor grade and radiation therapy were differentially linked with the likelihood of immediate breast reconstruction across patient age. Participants underwent mastectomy over a 14-year period ending in 2014. Investigators estimated the effect of age on IBR, and looked at the impact of tumor grade and radiation therapy. Among the results:
- ~One-fourth of women underwent IBR.
- Age was significantly linked with IBR.
- Younger women were more likely to undergo reconstruction.
- Tumor grade and radiation therapy altered the effect of age on IBR.
Reddy K, Strassle P, McGuire K. The role of age, tumor grade, and radiation therapy on immediate post-mastectomy breast reconstruction. [Published online ahead of print December 6, 2017]. Clin Breast Cancer. doi:10.1016/j.clbc.2017.11.021.
This Week's Must Reads
New MOC pathway developed by ABIM, ASCO, Alternative to focus on oncology expertise
Survey indicates opioid prescriptions have decreased , Physicians' progress to reverse the nation's opioid epidemic. American Medical Association.
Oncologists sue over Medicare drug pay cut, Community Oncology Alliance v. Office of Management and Budget et al.
Gender disparity found in oncology research funding, Zhou CD et al. BMJ Open. 2018 Apr 30. doi: 10.1136/bmjopen-2017-018625
Trump administration rejects ACA lawsuit, Texas v. The United States centers on the individual mandate
Must Reads in Breast Cancer
Taselisib and fulvestrant fall short in advanced ER+/HER2- breast cancer, Baselga et al. ASCO Abstract LBA1006.
Brain met outcomes similar for NSCLC, breast cancer patients, Cagney DN et al. JAMA Oncol. 2018 May 17. doi: 10.1001/jamaoncol.2018.0813.
Ketorolac during primary breast cancer surgery bettered diclofenac, Desmedt C et al. J Natl Cancer Inst. 2018 Apr 30. doi: 10.1093/jnci/djy042.
FDA Approves Lynparza for Certain Types of BC, FDA news release; 2018 Jan 12
Stereotactic Radiotherapy System Approved For BC, FDA news release; 2017 Dec 22